A 6.5% stake in Xtant Medical (XTNT) is reported alongside a foundation's 5% holding.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
An amended Schedule 13G filing for Xtant Medical Holdings, Inc. (XTNT) reports beneficial ownership for Lawrence W. Lytton and the Lytton-Kambara Foundation as of September 30, 2026. Lytton holds 6.5% of the class, while the Foundation holds 5.0%. Both percentages are calculated based on 140,287,960 common shares outstanding as of August 7, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.